Medtronic (NYSE: MDT) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The medical equipment company posted third-quarter revenue of $7.8 billion, up 1% year-over-year and in line with the Wall Street projection. Meanwhile, net income of $1.29 per share was higher than the target that analysts had anticipated.
MDT shares were down 0.8% immediately following the announcement. The stock has increased a modest 4% over the past 12 months.
“Looking ahead, we’re positioning ourselves for long-term success as we implement our new operating model and execute on a number of large opportunities to win share and create and disrupt big markets,” CEO Geoff Martha said in a statement.
Prior performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
